2012
DOI: 10.1038/modpathol.2011.141
|View full text |Cite
|
Sign up to set email alerts
|

Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones

Abstract: Adamantinoma of long bones and osteofibrous dysplasia are rare, osteolytic primary bone tumours of uncertain origin containing areas of fibrous and fibro-osseous proliferation. We investigated the nature of the stromal cells in adamantinoma of long bones and osteofibrous dysplasia, and determined cellular and molecular mechanisms of osteolysis in these tumours. Cell culture, molecular (RT-PCR, western blot) and immunohistochemical studies on cases of adamantinoma of long bones and of osteofibrous dysplasia wer… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
17
0

Year Published

2013
2013
2021
2021

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 22 publications
(17 citation statements)
references
References 23 publications
0
17
0
Order By: Relevance
“…However, osteofibrous dysplasia always present as a palpable mass with bone deformities. Furthermore, a number of cases present with pathologic fractures and high alkali phosphatase levels (13). Additional differential diagnoses include osteoblastic sarcoma and aneurysmal bone cysts.…”
Section: Discussionmentioning
confidence: 99%
“…However, osteofibrous dysplasia always present as a palpable mass with bone deformities. Furthermore, a number of cases present with pathologic fractures and high alkali phosphatase levels (13). Additional differential diagnoses include osteoblastic sarcoma and aneurysmal bone cysts.…”
Section: Discussionmentioning
confidence: 99%
“…Adamantinoma [3,[112][113][114][115][116] Progressive complexity of cytogenetic alterations including increased copy number of chromosomes 7, 8, 12, 19, and 21, KMT2D alterations and rare gene fusions…”
Section: Loss Of Multiple Tumor Suppressor Genesmentioning
confidence: 99%
“…Differentiated AD have been described as OFD‐like, regressive, juvenile, and intracortical AD. Distinguishing classic AD and OFD‐like AD is a controversial and critical distinction as significant controversy remains regarding prognosis and treatment of OFD‐like AD, as some consider OFD‐like AD to have no/low‐risk of metastasis, while others consider it a transitional state between benign OFD and more aggressive classic AD 9‐12 . Recent studies by Ali et al 13 show identification of KMT2D gene mutations and elevated expression of DLK1 protein in both subtypes of ADs, serving as a potential biomarker for distinguishing ADs from other lesions 13 .…”
Section: Introductionmentioning
confidence: 99%